GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (BUE:PFE) » Definitions » Accounts Payable & Accrued Expense

Pfizer (BUE:PFE) Accounts Payable & Accrued Expense : ARS8,896,078 Mil (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Pfizer Accounts Payable & Accrued Expense?

Pfizer's quarterly accounts payable & accrued expense increased from Sep. 2024 (ARS7,785,545 Mil) to Dec. 2024 (ARS11,089,800 Mil) but then declined from Dec. 2024 (ARS11,089,800 Mil) to Mar. 2025 (ARS8,896,078 Mil).

Pfizer's annual accounts payable & accrued expense increased from Dec. 2022 (ARS1,793,687 Mil) to Dec. 2023 (ARS4,126,591 Mil) and increased from Dec. 2023 (ARS4,126,591 Mil) to Dec. 2024 (ARS11,089,800 Mil).


Pfizer Accounts Payable & Accrued Expense Historical Data

The historical data trend for Pfizer's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Accounts Payable & Accrued Expense Chart

Pfizer Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 609,861.70 918,302.05 1,793,687.30 4,126,591.00 11,089,800.11

Pfizer Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,399,677.63 9,286,334.87 7,785,545.16 11,089,800.11 8,896,078.24

Pfizer Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Pfizer Business Description

Industry
Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.